Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

A series of aromatic sulfonamides incorporating indane moieties were prepared starting from commercially available 1- and 2-indanamine, and their activity as inhibitors of two carbonic anhydrase (CA, EC 4.2.1.1) isozymes, hCA I and II was studied. The new sulfonamides incorporating acetamido, 4-chloro-benzoyl, valproyl, tetra-, and pentafluorobenzoyl moieties acted as very potent inhibitors of the slow red blood cell isozyme hCA I (K(i)s in the range of 1.6-8.5 nM), which usually has a lower affinity for such inhibitors, as compared to isozyme II. Some derivatives also showed excellent hCA II inhibitory properties (K(i)s in the range of 2.3-12 nM), but the anticonvulsant activity of these sulfonamides was rather low as compared to that of other sulfonamide/sulfamate CA inhibitors, such as methazolamide. Furthermore, the 2-amino/acetamido-indane-5-sulfonic acids prepared during this work also showed interesting CA inhibitory properties, with inhibition constants in the range of 43-89 nM against the two isozymes, being among the most potent sulfonic acid CA inhibitors reported so far.

Knowledge Graph

Similar Paper

Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties
Bioorganic & Medicinal Chemistry Letters 2004.0
Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: Structure–activity relationship and pharmacological evaluation
European Journal of Medicinal Chemistry 2008.0
Carbonic Anhydrase Inhibitors:  Anticonvulsant Sulfonamides Incorporating Valproyl and Other Lipophilic Moieties
Journal of Medicinal Chemistry 2002.0
Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose–thioureido tails
Bioorganic & Medicinal Chemistry Letters 2007.0
Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors
Bioorganic & Medicinal Chemistry 2013.0
Discovery of Benzenesulfonamide Derivatives as Carbonic Anhydrase Inhibitors with Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Evaluation
Journal of Medicinal Chemistry 2018.0
Discovery of Potent Carbonic Anhydrase Inhibitors as Effective Anticonvulsant Agents: Drug Design, Synthesis, and In Vitro and In Vivo Investigations
Journal of Medicinal Chemistry 2021.0
Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies
European Journal of Medicinal Chemistry 2017.0
Discovery of Benzenesulfonamides with Potent Human Carbonic Anhydrase Inhibitory and Effective Anticonvulsant Action: Design, Synthesis, and Pharmacological Assessment
Journal of Medicinal Chemistry 2017.0
Synthesis and human/bacterial carbonic anhydrase inhibition with a series of sulfonamides incorporating phthalimido moieties
Bioorganic & Medicinal Chemistry 2017.0